Example: Heart Attack

Search clinical trials for: machine-learning algorithm

Total 10000 results

NCT03571607

Completed

A Safety And Immunogenicity Study Of A 13-valent Pneumococcal Conjugate Vaccine In Japanese Subjects Aged 6 To 64 Years.

Pneumococcal Infections
NCT03169725

Completed

A Clinical Study to Evaluate the Safety and Immunogenicity of Inactivated Poliomyelitis Vaccine in Healthy Infants

Poliomyelitis
NCT00306527

Completed

Comparison of Safety, Tolerability and Immunogenicity of Influenza Vaccines in Adults and Elderly

Influenza
NCT01119625

Completed

Immunological Persistence After Priming With GSK1024850A Vaccine and Safety& Immunogenicity After Booster Dose

Infections, Streptococcal
NCT01531322

Completed

A Study Assessing 13-valent Pneumococcal Conjugate Vaccine in Healthy Chinese Subjects

Pneumococcal Infection
NCT01640691

Completed

Immunogenicity and Safety of Pandemic Influenza Vaccine in Healthy Adults

Pandemic Influenza
NCT02797236

Completed

SF2a-TT15 Conjugate Vaccine in Healthy Adult Volunteers

Shigellosis | Bacillary Dysentery
NCT02433652

Completed

Evaluating the Safety and Protective Efficacy of a Single Dose of a Trivalent Live Attenuated Dengue Vaccine to Protect Against Infection With DENV-2

Dengue
NCT03405805

Unknown

Immunological Memory Against Pneumococcus Induced by 3 Infant PCV 13 Vaccination Schedules

Immunogenicity, Vaccine | Immunologic Memory
NCT01685372

Completed

Immunogenicity of Fluzone High Dose in Immunocompromised Children and Young Adults

Rheumatologic Disorder | Dialysis | Human Immunodeficiency Virus (HIV) | Solid Organ Transplant Recipient (Liver, Kidney, Heart) | Bone Marrow Transplant (BMT)
NCT01680679

Completed

Influenza Immunization of Children in India

Influenza
NCT02813486

Unknown

Safety and Immunogenicity Study of Tetanus, Diphtheria and Acellular Pertussis (Tdap) Vaccine

Whooping Cough | Tetanus | Diphtheria
NCT00379977

Completed

Study to Assess the Safety & Reactogenicity of GSK Biologicals' DTPa/Hib Vaccine When Given at 3, 4 and 5 Months of Age

Tetanus | Diphtheria | Acellular Pertussis | Haemophilus Influenzae Type b
NCT02915809

Unknown

A Study to Evaluate Efficacy and Safety of GC3110B in Healthy Adults

Influenza, Human
NCT02643433

Completed

Immunogenicity of Co-administration of Measles and Japanese Encephalitis Vaccines (MR+JE)

Japanese Encephalitis | Measles | Rubella
NCT02544698

Unknown

Safety Study of Pneumococcal 13-valent Conjugate Vaccine in Healthy People Aged 2 Months and Older

Pneumococcal 13-valent Conjugate Vaccine
NCT00307177

Completed

Trivalent Baculovirus-expressed Influenza HA Vaccine in Adults With Non-Hodgkin's B-cell Lymphoma

Influenza
NCT00655148

Completed

Safety and Immunogenicity of a New Serum-free DTaP-IPVvero Combination Vaccine

Active Immunization
NCT00978120

Completed

Safety and Efficacy of an H1N1 Influenza Vaccine in People With Asthma

H1N1 Influenza Virus
NCT00492557

Completed

Study Evaluating Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine With Influenza Vaccine in Adults

Pneumococcal Infections
NCT01026038

Completed

Study Evaluating Antibody Response Of 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) 24 Months After Toddler Dose.

Safety | Immunization | 13-valent Pneumococcal Vaccine | Antibody Response
NCT07253012

Recruiting

AI-Assisted Analgesia Copilot System (SEASCAPE)

Target Controlled Infusion (TCI) | Remifentanil Consumption | Artificial Intelligence (AI) | Nociception
NCT04548518

Recruiting

Immunogenicity and Safety of Tri Fluvac, a Seasonal Trivalent Inactivated Split Virion Influenza Vaccine, in Healthy Thai Elderly

Influenza
NCT07240922

Active, not recruiting

The Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE III) Study (DRIVE III)

Influenza
NCT04824638

Completed

BNT162b2 Vaccination With 2 Doses in COVID-19 Negative Volunteers and With a Single Dose in COVID-19 Positive Volunteers (CoviCompareP)

Healthy | Immunization; Infection
NCT06279871

Completed

Immunogenicity and Safety Study of Self-amplifying mRNA COVID-19 Vaccine Administered With Influenza Vaccines in Adults

COVID-19
NCT01527591

Active, not recruiting

Pneumococcal Conjugate Vaccine 13 (Prevnar13®) in Children Who Are Solid Organ Transplant Recipients (SOT)

Infection in Solid Organ Transplant Recipients
NCT05656508

Completed

ARVAC - A New Recombinant Coronavirus Disease 2019 (COVID-19) Vaccine

COVID-19 Vaccine
NCT00112957

Completed

Vaccine Therapy in Patients With Stage II, III, or IV Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity Cancer
NCT04001504

Completed

Vaccination Against Influenza to Prevent Cardiovascular Events After Acute Coronary Syndromes (VIP-ACS)

Acute Coronary Syndrome
NCT04885907

Completed

Third Dose of Moderna COVID-19 Vaccine in Transplant Recipients

Covid19 | Vaccine Response Impaired | Immune Suppression
NCT04475302

Completed

BCG Vaccine in Reducing Morbidity and Mortality in Elderly Individuals in COVID-19 Hotspots

COVID
NCT02915302

Completed

Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children

Influenza
NCT02787044

Completed

INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure (INVESTED)

Myocardial Infarction | Heart Failure
NCT04993560

Completed

Safety and Efficacy of COVID-19 Prime-boost Vaccine in Bahrain

Covid19 | SARS-CoV 2 Infection
NCT05065177

Completed

Safety and Immunogenicity Study of Live Attenuated Mumps Vaccines in Healthy Infants

Mumps
NCT02946385

Completed

Study to Assess the Immunological Long-term Persistence of Antibodies (Abs) 2 Years After GlaxoSmithKline (GSK) Meningococcal ABCWY Vaccination in the V102_15 (NCT02212457) and Response to a Booster in Adolescents

Infections, Meningococcal
NCT01148524

Completed

Assessment of Antibody Persistence at Eighteen Months After the Completion of the Vaccination Course in Study V72P10

Meningococcal Disease | Meningococcal Meningitis
NCT03555071

Completed

A Phase 3 Lot-consistency Clinical Trial of Live Attenuated Varicella Vaccine

Varicella
NCT01654224

Completed

Randomized Trial of High Dose Influenza Vaccine in Long Term Care Setting

Influenza
NCT01974817

Completed

Study Response of 13-valent Conjugate Pneumococcal Vaccine in Patients With End Stage Renal Disease

End Stage Renal Disease
NCT00914771

Completed

Safety and Immunogenicity of Two Doses, Administered Three Weeks Apart, of Two Monovalent H5N1 Influenza Vaccines Containing 2 Doses of H5N1 Influenza Antigen, in Non-elderly Adult and Elderly Subjects

Pandemic H5N1 Influenza
NCT00161811

Completed

Comparison of the Safety and Immune Response of Three Different Lots of an Influenza Vaccine Made by a New Manufacturing Process With a Vaccine Made by the Traditional Manufacturing Process for Season 2004/2005

Influenza
NCT01507857

Completed

An Efficacy Trial in Inactivated Enterovirus Type 71 (EV71) Vaccine

Hand, Foot and Mouth Disease
NCT01273233

Completed

Safety of an Inactivated Enterovirus Type 71 Vaccine in Healthy Adults

Infection; Viral, Enterovirus
NCT00227188

Completed

Study Evaluating Prevenar in the Prevention of Invasive Pneumococcal Disease (IPD) in the Paediatric Population in Spain.

Invasive Pneumococcal Disease
NCT01320176

Completed

Study to Evaluate the Dosage and Safety of Two Intramuscular Injections of an Investigational Clade B HIV Vaccine

HIV
NCT00219401

Completed

Neonatal Immunization With Pneumococcal Conjugate Vaccine in Papua New Guinea

Pneumonia | Meningitis | Otitis Media
NCT01096225

Unknown

Immunogenicity Study of S-OIV H1N1 Influenza Vaccine

Human Influenza
NCT00843895

Unknown

Multicenter Prospective Evaluation of the Incidence and Serotyes of Invasive Pneumoccocal Disease (IPD) Among Children Below 5 Years (Pneumococci)

Pneumococcal Disease

Search clinical trials for: machine-learning algorithm

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations